Equities

CVR Medical Corp

CVR Medical Corp

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 10 2022.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-2.69m
  • Incorporated1980
  • Employees--
  • Location
    CVR Medical Corp4664 Sierra View DriveDENVER 28037United StatesUSA
  • Phone+1 (734) 718-5115
  • Fax+1 (604) 669-0774
  • Websitehttp://cvrmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Solarvest Bioenergy Inc520.00-1.72m1.52m--------2,920.93-0.0289-0.02890.00001-0.0970.0005--0.0301---177.23-95.33---3,099.0757.69---330,076.90-75,194.81---8.39-----4.85---48.35--1.70--
Waverley Pharma Inc293.41k-2.15m1.89m--------6.44-0.0398-0.03980.0054-0.02590.1759--2.33---128.84-32.30---60.7526.5813.74-732.29-94.30---11.665.43---66.9513.03-234.91------
Lifeist Wellness Inc20.67m-13.27m1.98m72.00--1.74--0.0956-0.5105-0.51050.8110.03731.353.766.14---86.38-62.71-207.88-78.8131.6317.06-64.21-136.110.4947-907.570.5204---1.85--24.45------
CVR Medical Corp0.00-2.69m2.00m-----------0.0261-0.02610.00-0.06130.00-------322.06-341.11---------------2.46---------948.22------
Pond Technologies Holdings Inc3.67m-3.47m2.34m--------0.6389-0.0465-0.04650.0488-0.07320.88098.586.48---83.35-79.49---261.0421.7622.67-94.63-102.930.044-27.91-----11.565.1322.04---44.68--
Data as of May 10 2022. Currency figures normalised to CVR Medical Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.